ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication (2020)
Wong, Queenie Hoi-Wing; Wong, Gabriel Chun-Hei; Chan, Aden Ka-Yin; Poon, Wai Sang; Chan, Danny Tat-Ming; Chen, Hong; Zhang, Zhen-yu; Noushmehr, Houtan ; Jones, Chris; Grabovska, Yura; Mackay, Alan; Chow, Chit; Kwan, Johnny Sheung Him; Chung, Nellie Yuk-Fei; Huang, Queenie Junqi; Poon, Manix Fung-Man; Shi, Zhi-feng; Li, Kay Ka-Wai; Ng, Ho-Keung
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, SEQUENCIAMENTO GENÉTICO, RNA, GENÔMICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WONG, Queenie Hoi-Wing et al. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.704. Acesso em: 01 jun. 2024. , 2020
APA
Wong, Q. H. -W., Wong, G. C. -H., Chan, A. K. -Y., Poon, W. S., Chan, D. T. -M., Chen, H., et al. (2020). Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.704
NLM
Wong QH-W, Wong GC-H, Chan AK-Y, Poon WS, Chan DT-M, Chen H, Zhang Z-yu, Noushmehr H, Jones C, Grabovska Y, Mackay A, Chow C, Kwan JSH, Chung NY-F, Huang QJ, Poon MF-M, Shi Z-feng, Li KK-W, Ng H-K. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication [Internet]. Neuro-Oncology. 2020 ; 22 ii169.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noaa215.704
Vancouver
Wong QH-W, Wong GC-H, Chan AK-Y, Poon WS, Chan DT-M, Chen H, Zhang Z-yu, Noushmehr H, Jones C, Grabovska Y, Mackay A, Chow C, Kwan JSH, Chung NY-F, Huang QJ, Poon MF-M, Shi Z-feng, Li KK-W, Ng H-K. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication [Internet]. Neuro-Oncology. 2020 ; 22 ii169.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noaa215.704
Trabalho de evento-resumo periodico
Epigenomics of the glioma longitudinal analysis (glass) consortium (2020)
Sabedot, Thais; Wells, Michael; Datta, Indrani; Malta, Tathiane; Castro, Ana Valeria; Poisson, Laila M; Verhaak, Roel; Iavarone, Antonio; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais et al. Epigenomics of the glioma longitudinal analysis (glass) consortium. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.308. Acesso em: 01 jun. 2024. , 2020
APA
Sabedot, T., Wells, M., Datta, I., Malta, T., Castro, A. V., Poisson, L. M., et al. (2020). Epigenomics of the glioma longitudinal analysis (glass) consortium. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.308
NLM
Sabedot T, Wells M, Datta I, Malta T, Castro AV, Poisson LM, Verhaak R, Iavarone A, Noushmehr H. Epigenomics of the glioma longitudinal analysis (glass) consortium [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii75.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noaa215.308
Vancouver
Sabedot T, Wells M, Datta I, Malta T, Castro AV, Poisson LM, Verhaak R, Iavarone A, Noushmehr H. Epigenomics of the glioma longitudinal analysis (glass) consortium [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii75.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noaa215.308
Trabalho de evento-resumo periodico
Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon (2020)
Tesileanu, C. Mircea S.; Van den Bent, Martin; Sabedot, Thais; Sanson, Marc; Brandes, Alba; Wick, Wolfgang; Clement, Paul; Erridge, Sarah; Vogelbaum, Michael; Nowak, Anna; Baurain, Jean; Mason, Warren; Wheeler, Helen; Weller, Michael; Heer, Iris de; Dubbink, Hendrikus; Kros, Johan M; Aldape, Kenneth; Wesseling, Pieter; Golfinopoulos, Vassilis; Gorlia, Thierry; Baumert, Brigitta; Noushmehr, Houtan ; French, Pim
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.693. Acesso em: 01 jun. 2024. , 2020
APA
Tesileanu, C. M. S., Van den Bent, M., Sabedot, T., Sanson, M., Brandes, A., Wick, W., et al. (2020). Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.693
NLM
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693
Vancouver
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693
Trabalho de evento-resumo
Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma (2020)
Varn, Frederick; Johnson, Kevin; Barthel, Floris; Kim, Hoon; Wade, Taylor; Lodha, Disha; Ajaib, Shoaib; Ahmed, Nazia; Garofano, Luciano; D’Angelo, Fulvio; Stead, Lucy; Noushmehr, Houtan ; Iavarone, Antonio; Verhaak, Roel
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, SISTEMA IMUNE, SEQUENCIAMENTO GENÉTICO, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARN, Frederick et al. Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma. 2020, Anais.. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2020. p. ii70. Disponível em: https://doi.org/10.1093/neuonc/noaa215.287. Acesso em: 01 jun. 2024.
APA
Varn, F., Johnson, K., Barthel, F., Kim, H., Wade, T., Lodha, D., et al. (2020). Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma. In Neuro-Oncology (Vol. 22, p. ii70). Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.287
NLM
Varn F, Johnson K, Barthel F, Kim H, Wade T, Lodha D, Ajaib S, Ahmed N, Garofano L, D’Angelo F, Stead L, Noushmehr H, Iavarone A, Verhaak R. Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii70.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noaa215.287
Vancouver
Varn F, Johnson K, Barthel F, Kim H, Wade T, Lodha D, Ajaib S, Ahmed N, Garofano L, D’Angelo F, Stead L, Noushmehr H, Iavarone A, Verhaak R. Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii70.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noaa215.287
Trabalho de evento-resumo periodico
Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning (2019)
Snyder, James; Wells, Michael; Poisson, Laila; Kalkanis, Steven; Noushmehr, Houtan ; Robin, Adam
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: ENSAIO CLÍNICO, MENINGIOMA, GLÂNDULA PITUITÁRIA, NEOPLASIAS CEREBRAIS, ASTROCITOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SNYDER, James et al. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.558. Acesso em: 01 jun. 2024. , 2019
APA
Snyder, J., Wells, M., Poisson, L., Kalkanis, S., Noushmehr, H., & Robin, A. (2019). Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.558
NLM
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Vancouver
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Trabalho de evento-resumo periodico
Active transcription start sites of meningioma samples associated with risk of recurrence (2019)
Malta, Tathiane; Sabedot, Thais Sarra; Carlotti Júnior, Carlos Gilberto ; Noushmehr, Houtan
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: TRANSCRIÇÃO GÊNICA, MENINGIOMA, NEOPLASIAS CEREBRAIS, EPIGÊNESE GENÉTICA, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane et al. Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.460. Acesso em: 01 jun. 2024. , 2019
APA
Malta, T., Sabedot, T. S., Carlotti Júnior, C. G., & Noushmehr, H. (2019). Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.460
NLM
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Vancouver
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Trabalho de evento-resumo periodico
Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs (2019)
Berezovsky, Artem; Nuga, Oluwademilade; Meng, Yuling; Poisson, Laila; Noushmehr, Houtan ; Carvalho, Ana de
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, EXPRESSÃO GÊNICA, REGULAÇÃO GÊNICA, LINHAGEM CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEREZOVSKY, Artem et al. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.457. Acesso em: 01 jun. 2024. , 2019
APA
Berezovsky, A., Nuga, O., Meng, Y., Poisson, L., Noushmehr, H., & Carvalho, A. de. (2019). Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.457
NLM
Berezovsky A, Nuga O, Meng Y, Poisson L, Noushmehr H, Carvalho A de. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs [Internet]. Neuro-oncology. 2019 ; 21 vi109.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.457
Vancouver
Berezovsky A, Nuga O, Meng Y, Poisson L, Noushmehr H, Carvalho A de. Gene expression signature associated with aggressive glioblastoma growth is enriched in chromatin modification and stemness transcriptional regulation programs [Internet]. Neuro-oncology. 2019 ; 21 vi109.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.457
Trabalho de evento-resumo periodico
DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas (2019)
Wells, Michael; Sabedot, Thais Sarraf; Asmaro, Karam; Mosella, Maritza Queiroz Salas ; Malta, Tathiane; Nelson, Kevin; Snyder, James; Carvalho, Ana de; Mukherjee, Abir; Bahn, Arti; Robin, Adam; Rosenblum, Mark; Mikkelsen, Tom; Poisson, Laila; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Rock, Jack; Noushmehr, Houtan ; Chitale, Dhananjay; Castro, Anavaleria
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS, GLÂNDULA PITUITÁRIA, METILAÇÃO DE DNA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELLS, Michael et al. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.426. Acesso em: 01 jun. 2024. , 2019
APA
Wells, M., Sabedot, T. S., Asmaro, K., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2019). DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.426
NLM
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Vancouver
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Trabalho de evento-resumo periodico
Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma (2019)
Lee, Ian; Hunt, Rachel; Nelson, Kevin; Patil, Darshana; Datta, Vineet; Akolkar, Dadasaheb; Apurva, Sachin; Fulmali, Pooja; Puranik, Sneha; Snyder, James; Noushmehr, Houtan ; Devhare, Pradeep; Carvalho, Ana de; Datar, Rajan; Walbert, Tobias; Kalkanis, Steven
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, GLIOMA, LEUCEMIA, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEE, Ian et al. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.659. Acesso em: 01 jun. 2024. , 2019
APA
Lee, I., Hunt, R., Nelson, K., Patil, D., Datta, V., Akolkar, D., et al. (2019). Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.659
NLM
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Vancouver
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Trabalho de evento-resumo periodico
Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks (2019)
Li, Kay Ka-Wai; Chen, Hong; Noushmehr, Houtan ; Ng, Ho-Keung
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, MUTAÇÃO GENÉTICA, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LI, Kay Ka-Wai et al. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.611. Acesso em: 01 jun. 2024. , 2019
APA
Li, K. K. -W., Chen, H., Noushmehr, H., & Ng, H. -K. (2019). Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.611
NLM
Li KK-W, Chen H, Noushmehr H, Ng H-K. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks [Internet]. Neuro-oncology. 2019 ; 21 vi146.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.611
Vancouver
Li KK-W, Chen H, Noushmehr H, Ng H-K. Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks [Internet]. Neuro-oncology. 2019 ; 21 vi146.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.611
Trabalho de evento-resumo periodico
Methylation-based liquid biopsy of meningioma primary and recurrent samples (2019)
Sabedot, Thais Sarraf; Malta, Tathiane; Snyder, James; Walbert, Tobias; Lee, Ian; Kalkanis, Steven; Castro, Anavaleria; Noushmehr, Houtan
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: MENINGIOMA, NEOPLASIAS CEREBRAIS, BIÓPSIA, BIOMARCADORES, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.463. Acesso em: 01 jun. 2024. , 2019
APA
Sabedot, T. S., Malta, T., Snyder, J., Walbert, T., Lee, I., Kalkanis, S., et al. (2019). Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.463
NLM
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Vancouver
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Trabalho de evento-resumo periodico
Epigenomic glioma subtype evaluation across 31 tumor types (2017)
Mosella, Maritza; Sarraf, Thais; Malta, Tathiane; Chedraoui, Tiago; Noushmehr, Houtan; Castro, Ana Valéria
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza et al. Epigenomic glioma subtype evaluation across 31 tumor types. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 01 jun. 2024. , 2017
APA
Mosella, M., Sarraf, T., Malta, T., Chedraoui, T., Noushmehr, H., & Castro, A. V. (2017). Epigenomic glioma subtype evaluation across 31 tumor types. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Mosella M, Sarraf T, Malta T, Chedraoui T, Noushmehr H, Castro AV. Epigenomic glioma subtype evaluation across 31 tumor types [Internet]. Neuro-Oncology. 2017 ; 19 vi103-vi104.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Mosella M, Sarraf T, Malta T, Chedraoui T, Noushmehr H, Castro AV. Epigenomic glioma subtype evaluation across 31 tumor types [Internet]. Neuro-Oncology. 2017 ; 19 vi103-vi104.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/nox168
Trabalho de evento-resumo periodico
Predictive signature of malignant recurrence in G-CIMP tumors (2017)
Souza, Camila; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, DOENÇAS DO SISTEMA NERVOSO, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Camila e NOUSHMEHR, Houtan. Predictive signature of malignant recurrence in G-CIMP tumors. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 01 jun. 2024. , 2017
APA
Souza, C., & Noushmehr, H. (2017). Predictive signature of malignant recurrence in G-CIMP tumors. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Souza C, Noushmehr H. Predictive signature of malignant recurrence in G-CIMP tumors [Internet]. Neuro-Oncology. 2017 ; 19 vi98.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Souza C, Noushmehr H. Predictive signature of malignant recurrence in G-CIMP tumors [Internet]. Neuro-Oncology. 2017 ; 19 vi98.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/nox168
Trabalho de evento-resumo periodico
PD-L1 expression associated with glioma molecular subtypes: clinical implications (2017)
Malta, Tathiane; Snyder, James; Kalkanis, Steven; Castro, Ana Valéria; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane et al. PD-L1 expression associated with glioma molecular subtypes: clinical implications. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 01 jun. 2024. , 2017
APA
Malta, T., Snyder, J., Kalkanis, S., Castro, A. V., & Noushmehr, H. (2017). PD-L1 expression associated with glioma molecular subtypes: clinical implications. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Malta T, Snyder J, Kalkanis S, Castro AV, Noushmehr H. PD-L1 expression associated with glioma molecular subtypes: clinical implications [Internet]. Neuro-Oncology. 2017 ; 19 vi126.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Malta T, Snyder J, Kalkanis S, Castro AV, Noushmehr H. PD-L1 expression associated with glioma molecular subtypes: clinical implications [Internet]. Neuro-Oncology. 2017 ; 19 vi126.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/nox168
Trabalho de evento-resumo periodico
Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype (2017)
Sabedot, Thais Sarraf; Poisson, Laila; Carvalho, Ana C. de; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 01 jun. 2024. , 2017
APA
Sabedot, T. S., Poisson, L., Carvalho, A. C. de, & Noushmehr, H. (2017). Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Sabedot TS, Poisson L, Carvalho AC de, Noushmehr H. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype [Internet]. Neuro-Oncology. 2017 ; 19 vi105.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Sabedot TS, Poisson L, Carvalho AC de, Noushmehr H. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype [Internet]. Neuro-Oncology. 2017 ; 19 vi105.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/nox168
Artigo de periodico
Epigenomic stemness signature associated with glioma molecular subtypes (2016)
Malta, Tathiane; Wiznerowicz, Maciej; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane e WIZNEROWICZ, Maciej e NOUSHMEHR, Houtan. Epigenomic stemness signature associated with glioma molecular subtypes. Neuro-Oncology, v. 18, n. suppl_6, p. vi81, 2016Tradução . . Disponível em: https://doi.org/10.1093/neuonc/now212.340. Acesso em: 01 jun. 2024.
APA
Malta, T., Wiznerowicz, M., & Noushmehr, H. (2016). Epigenomic stemness signature associated with glioma molecular subtypes. Neuro-Oncology, 18( suppl_6), vi81. doi:10.1093/neuonc/now212.340
NLM
Malta T, Wiznerowicz M, Noushmehr H. Epigenomic stemness signature associated with glioma molecular subtypes [Internet]. Neuro-Oncology. 2016 ;18( suppl_6): vi81.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/now212.340
Vancouver
Malta T, Wiznerowicz M, Noushmehr H. Epigenomic stemness signature associated with glioma molecular subtypes [Internet]. Neuro-Oncology. 2016 ;18( suppl_6): vi81.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/now212.340
Trabalho de evento-resumo periodico
Epigenetic alterations at intergenic regions associated with progression in a subset of IDH mutant gliomas (2016)
Sabedot, Thais Sarraf; Malta, Tathiane; Ceccarelli, Michele; Dihn, Huy; Berman, Benjamin; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Epigenetic alterations at intergenic regions associated with progression in a subset of IDH mutant gliomas. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/now212.339. Acesso em: 01 jun. 2024. , 2016
APA
Sabedot, T. S., Malta, T., Ceccarelli, M., Dihn, H., Berman, B., & Noushmehr, H. (2016). Epigenetic alterations at intergenic regions associated with progression in a subset of IDH mutant gliomas. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/now212.339
NLM
Sabedot TS, Malta T, Ceccarelli M, Dihn H, Berman B, Noushmehr H. Epigenetic alterations at intergenic regions associated with progression in a subset of IDH mutant gliomas [Internet]. Neuro-Oncology. 2016 ; 18( suppl_6): vi81.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/now212.339
Vancouver
Sabedot TS, Malta T, Ceccarelli M, Dihn H, Berman B, Noushmehr H. Epigenetic alterations at intergenic regions associated with progression in a subset of IDH mutant gliomas [Internet]. Neuro-Oncology. 2016 ; 18( suppl_6): vi81.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1093/neuonc/now212.339

USP Schools

ReP

Filtros

Authors

Subjects

Non normalized affiliation

Countries of institutions of collaboration